GlassScriptPhysician profile
David J Blazer
NPI 1093718272
$10,568.58
in general payments reported to CMS, 2019-2025
39 companies · $1,664 in 2025
The $1,664 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,748 · 2020: $804 · 2021: $1,197 · 2022: $1,391 · 2023: $1,564 · 2024: $2,200 · 2025: $1,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,428.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,076.68 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,051.56 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $983.06 | 2021-2025 | Eliquis, Camzyos |
| Pfizer INC. | $830.43 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $783.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $745.38 | 2019-2025 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $724.12 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $593.04 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $509.86 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Sanofi-Aventis U.S. LLC | $462.33 | 2019-2023 | |
| Shockwave Medical, INC | $376.28 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $269.02 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $246.74 | 2021-2025 | |
| Abbott Laboratories | $194.96 | 2019-2025 | Assurity, Jot Dx |
| Regeneron Healthcare Solutions, INC. | $180.55 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $172.12 | 2021-2025 | Verquvo |
| Esperion Therapeutics, INC. | $170.07 | 2020-2023 | Nexletol |
| Baxter Healthcare | $160.40 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Vital Connect, INC | $147.86 | 2023-2024 | Vitalpatch Rtm |
| Philips North America LLC | $121.21 | 2024-2025 | Ecc Solutions, (Ck4) Mcot, Mcot |
| Novo Nordisk INC | $99.30 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lundbeck LLC | $67.31 | 2019-2020 | |
| Tactile Systems Technology INC | $63.96 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Actelion Pharmaceuticals US, INC. | $63.61 | 2025 | Opsumit, Uptravi |
| Abiomed | $62.16 | 2020-2023 | Impella |
| Inspire Medical Systems, INC. | $47.02 | 2024 | Inspire |
| Penumbra, INC. | $46.90 | 2023 | Indigo System |
| Bardy Diagnostics, INC. | $44.00 | 2019-2020 | |
| Vifor Pharma, INC. | $43.50 | 2021 | |
| Acist Medical Systems, INC. | $39.99 | 2019 | |
| Becton, Dickinson and Company | $31.43 | 2021 | |
| Venclose INC. | $28.38 | 2020 | |
| Angiodynamics, INC. | $24.33 | 2022 | |
| Genzyme Corporation | $21.19 | 2024 | |
| Daiichi Sankyo INC. | $20.83 | 2019 | |
| Reflow Medical INC | $18.18 | 2025 | |
| Terumo Medical Corporation | $18.17 | 2023 | Angio-Seal |
| Cardiovascular Systems INC. | $17.86 | 2019 | |
| Medtronic, INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.